News Release Date : 04/04/2012
Field Neurosciences Institute Participating in International Research Trial
The research team at Field Neurosciences Institute (FNI) is participating in an international clinical research trial to investigate a new treatment for traumatic brain injuries. The study will test whether the hormone progesterone helps decrease brain swelling in patients.
The trial, SyNAPSe, is taking place in over 22 countries and is seeking to enroll 1,180 patients worldwide with severe traumatic brain injury. St. Mary's of Michigan is one of only two hospitals to participate in Michigan. The study is now open to enrollment with Dr. Malcolm Field as the principal investigator.
More than 1.5 million Americans suffer traumatic brain injuries each year, and more than 50,000 of them die, according to the U.S. Centers for Disease Control and Prevention. Currently, there is no approved medication to improve outcomes following a traumatic brain injury.
Study participants, who are enrolled after their families give consent, will receive progesterone or a placebo through an IV. Neither the researchers nor the patients' families will know which is given. Patients will be evaluated for six months after injury